Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mepfor 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ansel Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Mepfor 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Mepfor 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Mepfor 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mepfor 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Consume this extended-release tablet with a meal.

Common Side effects of Mepfor 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Mepfor 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mepfor 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medicine with a meal.

How Mepfor 2mg/500mg Tablet SR works:

Mepfor SR tablets (2mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Mepfor 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mepfor 2mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Mepfor tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Mepfor 2mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Mepfor 2mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mepfor 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; Mepfor 2mg/500mg Tablet SR is contraindicated in cases of severe liver disease.

What if you forget to take Mepfor 2mg/500mg Tablet SR :

Should you forget a Mepfor 2mg/500mg SR tablet, take it immediately. If your next dose is imminent, however, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mepfor 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Mepfor 2mg/500mg Tablet SR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Mepfor 2mg/500mg Tablet SR use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but potentially dangerous, particularly for individuals with impaired kidney function, the elderly, or those who consume significant alcohol. Symptoms can include muscular aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Mepfor 2mg/500mg Tablet SR and seek immediate medical attention.
Glimepiride/Metformin 2mg/500mg extended-release tablets (Mepfor) combine two agents to manage type 2 diabetes mellitus in adults. This therapy enhances glycemic control when coupled with dietary modification and physical activity. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose output and increasing insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Mepfor 2mg/500mg sustained-release tablets may cause common adverse events including hypoglycemia, taste disturbances, nausea, abdominal pain, diarrhea, and cephalalgia. Rare but potentially severe reactions such as lactic acidosis are also possible. Prolonged administration can result in vitamin B12 deficiency.
Prolonged use of Mepfor 2mg/500mg sustained-release tablets can lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures proposed by some studies include annual supplemental Vitamin B12 intake.
Mepfor 2mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. Hypoglycemia risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Mepfor 2mg/500mg SR tablets with alcohol is unsafe due to the risk of lowered blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Mepfor 2mg/500mg Tablet S...
48
MRP 58
17% off